Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Brain Neoplasms × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 3 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms, Cystic, Mucinous, and Serous 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Agnosia 1

Interventions

Temozolomide 36 Radiotherapy 20 Radiosurgery 20 Cyclophosphamide 11 Radiation 10 Irinotecan 10 Etoposide 10 Magnetic Resonance Spectroscopy 9 Filgrastim 8 Erlotinib Hydrochloride 8 Carboplatin 8 pembrolizumab 7 Surgical Procedures, Operative 7 Carmustine 7 Bevacizumab 7 Vincristine 6 Sorafenib 6 Flucytosine 6 Aminolevulinic Acid 6 temsirolimus 5 sargramostim 5 Topotecan 5 O(6)-benzylguanine 5 Nivolumab 5 Imatinib Mesylate 5 Granulocyte Colony-Stimulating Factor 5 Everolimus 5 cediranib 4 Vorinostat 4 Valproic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡